This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
All logs
From Proteopedia
Combined display of all available logs of Proteopedia. You can narrow down the view by selecting a log type, the user name, or the affected page.
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)
- 23:30, 1 July 2013 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:3ttp.pdb.jpg"
- 21:30, 1 July 2013 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Jmol.png"
- 23:33, 2 December 2012 Jamie C. Gladfelder (Talk | contribs) Sandbox reserved Herceptin moved to Herceptin - Mechanism of Action (revert)
- 22:13, 9 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:New Resource 1.jpg"
- 16:00, 8 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:EGFRs Mechanism.png" (This picture illustrates the mechanism in which EGFR, HER3, and HER4 change conformation in order to dimerize and activate further cell signaling. A) Sub-domain I (green) is sepearated from sub-domain III (blue). Sub-domain II (red) forms an interaction ()
- 15:52, 8 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded a new version of "Image:EGFR Mechanism.png"
- 16:23, 7 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Human Chromosome 17.jpg" (Human Chromosome 17)
- 23:51, 6 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Receptor Mechanism.png" (This picture illustrates the mechanism in which EGFR, HER3, and HER4 change conformation in order to dimerize and activate further cell signaling. A) Sub-domain I (green) forms an interaction (purple line) with sub-domain III (blue). Sub-domain II (red) f)
- 23:46, 6 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded a new version of "Image:Mechanism.png" (This picture illustrates the mechanism in which EGFR, HER3, and HER4 change conformation in order to dimerize and activate further cell signaling. A) Sub-domain I (green) forms an interaction (purple line) with sub-domain III (blue). Sub-domain II (red) f)
- 19:27, 6 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Conformational Change.png" (This picture illustrates the mechanism in which EGFR, HER3, and HER4 change conformation in order to dimerize and activate further cell signaling. A) Sub-domain I (green) forms an interaction (purple line) with sub-domain III (blue). Sub-domain II (red) f)
- 18:38, 6 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:EGFR Mechanism.png" (This picture illustrates the mechanism in which EGFR, HER3, and HER4 change conformation in order to dimerize and activate further cell signaling. A) Sub-domain I (green) forms an interaction (purple line) with sub-domain III (blue). Sub-domain II (red))
- 18:26, 6 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:EGFR.png"
- 14:25, 2 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Three Domains.jpg"
- 17:42, 1 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:HER family.jpg"
- 17:35, 1 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:EGFRs.png"
- 17:25, 1 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:HerceptinFab.jpg"
- 17:24, 1 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded "Image:Herceptin.jpg"
- 17:18, 1 November 2012 Jamie C. Gladfelder (Talk | contribs) uploaded a new version of "Image:Picture2.jpg"
